With Only 15% of Diagnosed HCV Patients Receiving Treatment, the Non-Profit I-MAK Hopes to Shift the National Conversation on Drug Pricing

The Body Pro

Media Article 21 May 2018

Join us to stay updated
and help make lifesaving medicines accessible to all